Episode Details
Back to Episodes
JAMA Neurology : Gefurulimab and Generalized Myasthenia Gravis
Published 2 months ago
Description
Interview with Kelly G. Gwathmey, MD, author of Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis: The PREVAIL Phase 3 Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD.
Related Content: